A case is presented in which a 7-month-old child developed central nervous system depression, urinary abnormalities and a large anion-gap acidosis after the accidental oral administration of clove oil. Supportive care and gastric lavage were sufficient for total recovery of the patient. Possible mechanisms of the depression and acidosis are discussed, and suggestions for treatment are presented.
Get full access to this article
View all access options for this article.
References
1.
Opdyke Dlj.Monographs on fragrance raw materials. Clove bud oil. Food Chemistry Toxicology1975; 13: 761-3.
2.
Guidotti TL, Binder S., Stratton JW, Schechter FG & Jenkins RAClove cigarettes: Development of the fad and evidence for health effects. In: Current Topics in Pulmonary Pharmacology and Toxicology, Vol 2, ed Hollinger MA , pp. 1-23. New York: Elsevier, 1987.
3.
Council on Scientific Affairs, AMA.Evaluation of the health hazard of clove cigarettes. Journal of the American Medical Association1988; 260: 3641-4.
4.
Ellenhorn MJ & Barceloux DGMedical Toxicology. Diagnosis and Treatment of Human Poisoning, p. 920. New York: Elsevier, 1988.
5.
Collins JFHealth hazards of clove cigarettes. Office of Environmental Health Hazard Assessment. California Department of Health Services, 1988.
6.
Hollander F. & Goldfischer RLHistological study of the destruction and regeneration of the gastric mucous barrier following appication of eugenol. Preliminary report. Journal of theNational Cancer Institute1949; 10: 339-46.
7.
Schroder V. & Vollmer H.Uber die ausscheidung von thymol, carvacrol, eugenol und guaiacol und die verteilung dieser substanzen im organismus. Naunyn Schmiedebergs Archives of Experimental Pathology Pharmacology1932; 168: 331-53.
8.
Weinberg JE, Barbag H., Nahas G. & Rabinowitz JLThe invivo and in-vitro metabolism of 14C eugenol in the rat. Journal of Dental Research1972; 51: 177.
9.
Dallmeier K. & Carlini EAAnesthetic, hypothermia, myorelaxant and anticonvulsant effects of synthetic eugenol derivatives and natural analogues. Pharmacology1981; 22: 113-27.
10.
Dallmeier-Zelger KR, Zelger JL & Carlini EANew anticonvulsants derived from 4-allyl-2 methoxyphenol (eugenol): Comparison with common antiepileptics in mice. Pharmacology1983; 2740-9.
11.
Sell AB & Carlini EAAnesthetic action of methyl eugenol and other eugenol derivatives. Pharmacology1976; 14: 367-77.
12.
Kozam G.The effect of eugenol on nerve transmission. Oral Surgery1977; 44: 799-805.
13.
Isaac G.Permanent local anaesthesia and anhidrosis after clove oil spillage. Lancet1983; 1: 882.
14.
Kozam G. & Mantell GMEffect of eugenol on oral mucous membranes. Journal of Dental Research1978; 57: 954-7.
15.
Hartiala Kjw , Pulkinnen M. & Ball P. Inhibition ofBeta-D-Glucosiduronic acid conjugation by eugenol. Nature1966; 210: 739-40.
16.
Cotmore JM, Burke A., Lee NH & Shapiro IMRespiratory inhibition of isolated rat liver mitochondria by eugenol. Archives of Oral Biology1979; 24: 565-8.
17.
Rasheed A., Laekemast G., Totte J. et al. Eugenol and prostaglandin biosynthesis. New England Journal of Medicine1984; 310: 50-1.
18.
Fotos PG, Woolverton CJ, Mokas MJ et al. Effect of eugenol on prostaglandin E levels in polymorphonuclear cells and serum. Annals of Dentistry1988; 417: 19-22.
